{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:02:52Z","timestamp":1779930172631,"version":"3.53.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.numecd.2021.11.018","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T20:02:29Z","timestamp":1638820949000},"page":"1010-1018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Female fragile X premutation carriers are at increased risk for metabolic syndrome from early adulthood"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-3250","authenticated-orcid":false,"given":"Noah","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach Marom","family":"Haham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LidiaV.","family":"Gabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Berkenstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Ries-Levavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-8091","authenticated-orcid":false,"given":"Orit","family":"Pinhas-Hamiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.numecd.2021.11.018_bib1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1542\/peds.2010-3500","article-title":"Health supervision for children with fragile X syndrome","volume":"127","author":"Hersh","year":"2011","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.numecd.2021.11.018_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","volume":"146A","author":"Coffey","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.numecd.2021.11.018_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0004.2009.01317.x","article-title":"Co-occurring diagnoses among FMR1 premutation allele carriers","volume":"77","author":"Hunter","year":"2010","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.numecd.2021.11.018_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1866-1955-6-30","article-title":"Associated features in females with an FMR1 premutation","volume":"6","author":"Wheeler","year":"2014","journal-title":"J Neurodev Disord"},{"issue":"11","key":"10.1016\/j.numecd.2021.11.018_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/genes7110101","article-title":"Endocrine dysfunction in female FMR1 premutation carriers: characteristics and association with ill health","volume":"7","author":"Campbell","year":"2016","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1016\/j.numecd.2021.11.018_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12311-016-0804-y","article-title":"Fragile X premutation carrier epidemiology and symptomatology in Israel\u2013results from a tertiary child developmental center","volume":"15","author":"Gabis","year":"2016","journal-title":"Cerebellum"},{"issue":"8","key":"10.1016\/j.numecd.2021.11.018_bib7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/ajmg.a.34113","article-title":"The FRAXopathies: definition, overview, and update","volume":"155A","author":"Pirozzi","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.numecd.2021.11.018_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice. Primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.numecd.2021.11.018_bib9","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1210\/jc.2004-0347","article-title":"Evidence of early ovarian aging in fragile X premutation carriers","volume":"89","author":"Welt","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.numecd.2021.11.018_bib10","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/humrep\/den050","article-title":"Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study","volume":"23","author":"Rohr","year":"2008","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.numecd.2021.11.018_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ejhg.5201510","article-title":"Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers","volume":"14","author":"Ennis","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.numecd.2021.11.018_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction","volume":"20","author":"Sullivan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.numecd.2021.11.018_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41436-021-01177-y","article-title":"Refining the risk for fragile X\u2013associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size","author":"Allen","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.numecd.2021.11.018_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1866-1955-6-26","article-title":"Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)","volume":"6","author":"Sherman","year":"2014","journal-title":"J Neurodev Disord"},{"issue":"8","key":"10.1016\/j.numecd.2021.11.018_bib15","doi-asserted-by":"crossref","first-page":"e105121","DOI":"10.1371\/journal.pone.0105121","article-title":"Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers","volume":"9","author":"Elizur","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2021.11.018_bib16","first-page":"1","article-title":"FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency","author":"Elizur","year":"2015","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"10.1016\/j.numecd.2021.11.018_bib17","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2016-1141","article-title":"Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age","volume":"101","author":"Daan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.numecd.2021.11.018_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2047487314556004","article-title":"Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis","volume":"23","author":"Roeters van Lennep","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"9491","key":"10.1016\/j.numecd.2021.11.018_bib19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2021.11.018_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pmedr.2017.07.004","article-title":"Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis","volume":"7","author":"Nolan","year":"2017","journal-title":"Prev Med reports"},{"issue":"11","key":"10.1016\/j.numecd.2021.11.018_bib21","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diacare.27.11.2676","article-title":"Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease?","volume":"27","author":"Stern","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.11.018_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jadohealth.2019.11.315","article-title":"Primary ovarian insufficiency nationwide incidence rate and etiology among Israeli adolescents","author":"Gruber","year":"2020","journal-title":"J Adolesc Health"},{"issue":"16","key":"10.1016\/j.numecd.2021.11.018_bib23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.numecd.2021.11.018_bib24","first-page":"219","article-title":"Overweight and obesity prevalence in Israel: findings of the first national health and nutrition survey (MABAT)","volume":"7","author":"Keinan-Boker","year":"2005","journal-title":"Isr Med Assoc J"},{"issue":"7","key":"10.1016\/j.numecd.2021.11.018_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/07853890802004959","article-title":"The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology","volume":"40","author":"Despr\u00e9s","year":"2008","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.numecd.2021.11.018_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/2047487313492631","article-title":"Coronary heart disease incidence in women by waist circumference within categories of body mass index","volume":"20","author":"Canoy","year":"2013","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"10.1016\/j.numecd.2021.11.018_bib27","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.numecd.2021.11.018_bib28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/ene.12738","article-title":"Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability","volume":"22","author":"Pinhas-Hamiel","year":"2015","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.numecd.2021.11.018_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41436-019-0733-5","article-title":"Clustering of comorbid conditions among women who carry an FMR1 premutation","volume":"22","author":"Allen","year":"2020","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.numecd.2021.11.018_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12311-016-0805-x","article-title":"Aging in fragile X premutation carriers","volume":"15","author":"Lozano","year":"2016","journal-title":"Cerebellum"},{"issue":"1","key":"10.1016\/j.numecd.2021.11.018_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001776","article-title":"Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis","volume":"9","author":"Gujral","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"10.1016\/j.numecd.2021.11.018_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabres.2015.09.003","article-title":"Comparison between indexes of insulin resistance for risk prediction of cardiovascular diseases or development of diabetes","volume":"110","author":"Zethelius","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2021.11.018_bib33","series-title":"Israel center for disease control (ICDC)","first-page":"112","author":"Shohat","year":"2016"},{"issue":"19","key":"10.1016\/j.numecd.2021.11.018_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015801","article-title":"Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population: The tg-real retrospective cohort analysis","volume":"9","author":"Arca","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"10.1016\/j.numecd.2021.11.018_bib35","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2021.11.018_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1399-0004.2011.01723.x","article-title":"CGG repeat in the FMR1 gene: size matters","volume":"80","author":"Willemsen","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.numecd.2021.11.018_bib37","article-title":"Low levels of HDL in fragile X syndrome patients","author":"Lisik","year":"2015","journal-title":"Lipids"},{"issue":"11","key":"10.1016\/j.numecd.2021.11.018_bib38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.numecd.2021.11.018_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00678","article-title":"Fmr1-deficiency impacts body composition, skeleton, and bone microstructure in a mouse model of fragile X syndrome","volume":"10","author":"Leboucher","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.numecd.2021.11.018_bib40","doi-asserted-by":"crossref","first-page":"e0174301","DOI":"10.1371\/journal.pone.0174301","article-title":"New insights of altered lipid profile in fragile X syndrome","volume":"12","author":"\u00c7aku","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2021.11.018_bib41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41371-019-0273-0","article-title":"The association between metabolic syndrome components and the development of atherosclerosis","volume":"33","author":"Aboonabi","year":"2019","journal-title":"J Hum Hypertens"},{"issue":"10","key":"10.1016\/j.numecd.2021.11.018_bib42","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2021.11.018_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.28.2.385","article-title":"The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study","volume":"28","author":"McNeill","year":"2005","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.numecd.2021.11.018_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/molehr\/gaaa057","article-title":"The molecular mechanisms that underlie fragile X-associated premature ovarian insufficiency: is it RNA or protein based?","volume":"26","author":"Rosario","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.numecd.2021.11.018_bib46","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-9080-1_14","article-title":"Pathophysiology mechanisms in fragile-X primary ovarian insufficiency","author":"Elizur","year":"2019"},{"issue":"1","key":"10.1016\/j.numecd.2021.11.018_bib47","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1080\/21691401.2019.1645153","article-title":"Association between the FMR1 CGG repeat lengths and the severity of idiopathic primary ovarian insufficiency: a meta analysis","volume":"47","author":"Huang","year":"2019","journal-title":"Artif Cell Nanomed Biotechnol"},{"key":"10.1016\/j.numecd.2021.11.018_bib48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/386296","article-title":"The fragile-X premutation: a maturing perspective","volume":"74","author":"Hagerman","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.numecd.2021.11.018_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.00266","article-title":"Fragile X premutation associated conditions (FXPAC)","volume":"8","author":"Johnson","year":"2020","journal-title":"Front Pediatr"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321005603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321005603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:22:22Z","timestamp":1760545342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321005603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0939475321005603"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.11.018","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Female fragile X premutation carriers are at increased risk for metabolic syndrome from early adulthood","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}